JPWO2023105035A5 - - Google Patents
Info
- Publication number
- JPWO2023105035A5 JPWO2023105035A5 JP2024534196A JP2024534196A JPWO2023105035A5 JP WO2023105035 A5 JPWO2023105035 A5 JP WO2023105035A5 JP 2024534196 A JP2024534196 A JP 2024534196A JP 2024534196 A JP2024534196 A JP 2024534196A JP WO2023105035 A5 JPWO2023105035 A5 JP WO2023105035A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- hyperglycemia
- disorder characterized
- treatment
- syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2117828.0 | 2021-12-09 | ||
| GB2117828.0A GB2613616A (en) | 2021-12-09 | 2021-12-09 | New formulations |
| PCT/EP2022/085133 WO2023105035A1 (en) | 2021-12-09 | 2022-12-09 | Crystalline form of (r)-2-(tert-butylamino)-1-(5-fluoropyridin-3-yl)-ethan-1-ol hemi-tartrate salt for the treatment of hyperglycemia and diabetes 2 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024544698A JP2024544698A (ja) | 2024-12-03 |
| JP2024544698A5 JP2024544698A5 (https=) | 2025-12-05 |
| JPWO2023105035A5 true JPWO2023105035A5 (https=) | 2025-12-05 |
Family
ID=80079964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534196A Pending JP2024544698A (ja) | 2021-12-09 | 2022-12-09 | 高血糖症及び２型糖尿病の治療のための（ｒ）－２－（ｔｅｒｔ－ブチルアミノ）－１－（５－フルオロピリジン－３－イル）－エタン－１－オールヘミ酒石酸塩の結晶形態 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250042856A1 (https=) |
| EP (1) | EP4444699A1 (https=) |
| JP (1) | JP2024544698A (https=) |
| KR (1) | KR20240116482A (https=) |
| CN (1) | CN118525004A (https=) |
| AU (1) | AU2022405700A1 (https=) |
| CA (1) | CA3241501A1 (https=) |
| GB (1) | GB2613616A (https=) |
| IL (1) | IL313292A (https=) |
| MX (1) | MX2024006960A (https=) |
| WO (1) | WO2023105035A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4651867A1 (en) | 2023-01-20 | 2025-11-26 | Atrogi AB | Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting |
| GB202303229D0 (en) * | 2023-03-06 | 2023-04-19 | Atrogi Ab | New medical uses |
| WO2025238248A1 (en) | 2024-05-17 | 2025-11-20 | Atrogi Ab | USE OF β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201714745D0 (en) * | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| WO2020198466A1 (en) * | 2019-03-27 | 2020-10-01 | Curasen Therapeutics, Inc. | Beta adrenergic agonist and methods of using the same |
-
2021
- 2021-12-09 GB GB2117828.0A patent/GB2613616A/en active Pending
-
2022
- 2022-12-09 AU AU2022405700A patent/AU2022405700A1/en active Pending
- 2022-12-09 CA CA3241501A patent/CA3241501A1/en active Pending
- 2022-12-09 MX MX2024006960A patent/MX2024006960A/es unknown
- 2022-12-09 CN CN202280081693.4A patent/CN118525004A/zh active Pending
- 2022-12-09 WO PCT/EP2022/085133 patent/WO2023105035A1/en not_active Ceased
- 2022-12-09 EP EP22835607.7A patent/EP4444699A1/en active Pending
- 2022-12-09 IL IL313292A patent/IL313292A/en unknown
- 2022-12-09 US US18/717,134 patent/US20250042856A1/en active Pending
- 2022-12-09 JP JP2024534196A patent/JP2024544698A/ja active Pending
- 2022-12-09 KR KR1020247020161A patent/KR20240116482A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024001048A5 (https=) | ||
| US20150011637A1 (en) | Crystal form of prostaglandin analogue, and preparation method and use thereof | |
| JP7566378B2 (ja) | アニソマイシン誘導体、アニソマイシン及びその誘導体をｇｌｐ－１ｒ作動薬としての使用方法 | |
| TWI391135B (zh) | 抗菌劑的腸胃外製劑 | |
| US10543298B2 (en) | Salts of tetracyclines | |
| RU2007101653A (ru) | Производные 1-азабицикло[3.3.1]нонанов | |
| CN1275936C (zh) | 羟基去甲麻黄素衍生物的各种结晶体型 | |
| WO2020249602A1 (en) | Methods for treating pulmonary arterial hypertension | |
| EP2124930B1 (en) | Isosorbide mononitrate derivatives for the treatment of intestinal disorders | |
| JP2009541455A5 (https=) | ||
| EP4585593A1 (en) | Polymorph of glp-1r agonist compound, preparation method therefor, and use thereof | |
| WO2005023766A1 (en) | Salt of atorvastatin with metformin | |
| WO2008060093A1 (en) | Crystalline s-(-)-amlodipine maleic acid salt anhydride and preparation method thereof | |
| CN103833713A (zh) | 硝克柳胺化合物晶iii型、其制法和其药物组合物与用途 | |
| JPWO2023105035A5 (https=) | ||
| JP3853389B2 (ja) | 新規の３−フェニルスルホニル−３，７−ジアザビシクロ［３，３，１］ノナン−化合物、その製法及び抗不整脈剤 | |
| US20260028332A1 (en) | Polymorphic form of glp-1r agonist, preparation method therefor and use thereof | |
| RU2024116274A (ru) | Кристаллическая форма гемитартратной соли (r)-2-(трет-бутиламино)-1-(5-фторпиридин-3-ил)-этан-1-ола для лечения гипергликемии и диабета 2-го типа | |
| JPH0322384B2 (https=) | ||
| JP2024170613A (ja) | Ｓｓｔｒ４アゴニスト及びその塩の調製のための方法並びに使用のための用量レジメン | |
| US8362263B2 (en) | Crystalline S-(−)-amlodipine adipic acid salt anhydrous and preparation method thereof | |
| CN1455770A (zh) | (2－氮杂二环[2.2.1]庚烷－7－基)甲醇衍生物作为烟碱类乙酰胆碱受体激动剂 | |
| CN113082023B (zh) | P2x3抑制剂和p2x4抑制剂的药物组合及其应用 | |
| JPWO2022122914A5 (https=) | ||
| KR100843401B1 (ko) | 결정성 ｓ-(-)-암로디핀 캠실레이트 무수물 및 이의제조방법 |